{"id":"W4405107409","doi":"10.1182/blood-2024-212970","title":"Tafasitamab Plus Lenalidomide and Rituximab for Relapsed or Refractory Follicular Lymphoma: Results from a Phase 3 Study (inMIND)","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Lenalidomide; Rituximab; Follicular lymphoma; Medicine; Refractory (planetary science); Oncology; Internal medicine; Phases of clinical research; Lymphoma; Clinical trial; Multiple myeloma; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003136483,0.001687667,0.002855019,0.0004313594,0.0006016756,0.001356888,0.001407468,0.001154772,0.003756456],"category_scores_gemma":[0.001371036,0.0006360906,0.002858834,0.0005394012,0.001016271,0.001007368,0.0005153239,0.003167111,0.0009575881],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001591601,"about_ca_system_score_gemma":0.001872715,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001446124,"about_ca_topic_score_gemma":0.00304337,"domain_scores_codex":[0.9992166,0.0003867594,0.00004836684,0.000137827,0.00008492541,0.0001255384],"domain_scores_gemma":[0.9990362,0.0001470109,0.0001687843,0.0001186258,0.0001099101,0.0004194602],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8332231,0.05659029,0.007230945,0.001327205,0.00521668,0.0002494931,0.0002877426,0.00100953,0.01959524,0.0001866697,0.003792479,0.07129057],"study_design_scores_gemma":[0.6822845,0.2892616,0.01770636,0.0001094745,0.003294487,0.0003804689,0.0001049818,0.0005665966,0.001865833,0.0002050177,0.004178301,0.00004232338],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9826345,0.006672028,0.0007843083,0.0007068405,0.0001694931,0.00368273,0.002606844,0.0001428313,0.00260032],"genre_scores_gemma":[0.9786965,0.004188046,0.002561051,0.001429551,0.0003405276,0.003538785,0.006931632,0.00006639783,0.002247555],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003756456,"threshold_uncertainty_score":0.0165875,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02853263491178453,"score_gpt":0.3116804466416099,"score_spread":0.2831478117298253,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}